Search Within

Stephen D Nimer

  1. "Lymphoma"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (19)
Groups
  1. Center for Hematologic Malignancies (41)
  2. Department of Medicine (41)
  3. Hematologic Malignancies, Division of (41)
  4. Lymphoma (41)
  5. Survivorship Research (27)
  6. Radiation Oncology, Department of (26)

More Groups

People
  1. Andrew Zelenetz (40)
  2. Craig Moskowitz (39)
  3. Joachim Yahalom (26)
  4. Tarun Kewalramani (23)
  5. Carol Portlock (16)
  6. David Straus (14)

More People

Years
  1. 2017 (1)
  2. 2012 (1)
  3. 2010 (1)
  4. 2008 (2)
  5. 2007 (2)
  6. 2006 (1)

More Years

Publications
  1. Blood (28)
  2. British Journal of Haematology (3)
  3. Annals of Oncology (2)
  4. Bone Marrow Transplantation (2)
  5. Journal of Clinical Oncology (2)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. John Wiley & Sons (3)
  3. Oxford University Press (3)
  4. American Society of Clinical Oncology (2)
  5. Nature Publishing Group (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Factors predicting outcome in patients with primary refractory intermediate grade lymphoma (IGL) eligible for high dose chemoradiotherapy (HDT) and autologous stem cell transplant (ASCT)
    Meeting Abstract

    Kewalramani, T.; Hedrick, E. E.; Donnelly, G. B.; Satagopan, J. M.; Hunte, S.; Priovolos, A.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (1999)

    Fulltext@MSK | Save
  • Persistent gallium avidity after second-line chemotherapy in Hodgkin's disease (HD) and intermediate-grade non-hodgkin's lymphoma (IGL) does not predict outcome following autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Donnelly, G. B.; Hedrick, E. E.; Kewalramani, T.; Satagopan, J. M.; Walits, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (1999)

    Fulltext@MSK | Save
  • Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant- eligible patients with non-Hodgkin's lymphoma
    Journal Article

    Moskowitz, C. H.; Bertino, J. R.; Glassman, J. R.; Hedrick, E. E.; Hunte, S.; Coady-Lyons, N.; Agus, D. B.; Goy, A.; Jurcic, J.; Noy, A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Glassman, J. R.; Portlock, C. S.; Yahalom, J.; Straus, D. J.; O'Brien, J. P.; Elkin, N.; Bertino, J. R.; Zelenetz, A. D.
    Bone Marrow Transplantation (1999)

    Fulltext@MSK | Save
  • Safety and efficacy of high dose therapy and peripheral blood progenitor cell transplantation (HDT/PBPCT) in patients with non-Hodgkin's lymphoma (NHL) over the age of 55 years
    Meeting Abstract

    Hedrick, E. E.; Nimer, S. D.; Zelenetz, A. D.; Childs, B.; Frank, R.; Malhotra, S.; Coady-Lyons, N.; Yahalom, J.; Moskowitz, C. H.
    Blood (1998)

    Fulltext@MSK | Save
  • A randmized phase II study of peripheral blood progenitor cell (PBPC) mobilization using chemotherapy followed by G-CSF with or without stem cell factor (SCF) in patients with Hodgkin's disease (HD), non-Hodgkin's lymphoma (NHL), and multiple myeloma (MM)
    Meeting Abstract

    Hedrick, E. E.; Nimer, S. D.; Zelenetz, A. D.; Gabrilove, J.; Wyres, M.; Gencarelli, A.; Karp, P.; Moskowitz, C. H.
    Blood (1998)

    Fulltext@MSK | Save
  • Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma
    Journal Article

    Moskowitz, C. H.; Glassman, J. R.; Wuest, D.; Maslak, P.; Reich, L.; Gucciardo, A.; Coady-Lyons, N.; Zelenetz, A. D.; Nimer, S. D.
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save
  • Ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) cytoreduction followed by high dose chemoradiotherapy and ASCT for refractory and relapsed Hodgkin's disease (HD): An intent to treat study
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Portlock, C. S.; Straus, D. J.; Pearse, R.; O'Brien, J. P.; Berger, M.; Gardner, S.; Trippett, T. M.; Zelenetz, A. D.; more...
    Blood (1997)

    Fulltext@MSK | Save
  • Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma
    Meeting Abstract

    Moskowitz, C. H.; Glassman, J. R.; Wuest, D.; Reich, L.; Gucciardo, A.; Coady-Lyons, N.; Zelenetz, A. D.; Nimer, S. D.
    Blood (1996)

    Fulltext@MSK | Save
  • The AML1/ETO fusion protein activates transcription of BCL-2
    Journal Article

    Klampfer, L.; Zhang, J.; Zelenetz, A. O.; Uchida, H.; Nimer, S. D.
    Proceedings of the National Academy of Sciences of the United States of America (1996)

    Fulltext@MSK | Save